1-17 of 17
Andreu Llorente
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact Of European Leukemia Net (ELN) Genetic Classification On The Outcome Of Allogeneic Stem Cell Transplantation (ALLOHCT) For Acute Myeloid Leukemia (AML) In First Complete Remission

Jorge Sierra, PhD, MD, Ana Garrido, MD, Mar Tormo, MD, Ramon Guardia, MD, Josep F Nomdedeu, MD, Jordi Esteve, MD, PhD, Josep-Maria Ribera, MD, PhD, Rafael F. Duarte, MD, PhD, M. Paz Queipo De Llano, MD, Olga Salamero, MD, Carmen Pedro, MD, Joan Bargay, MD, Juan Besalduch, MD, PhD, Andreu Llorente, MD, Montserrat Hoyos, Montserrat Arnan, MD, Marta Pratcorona, MD, Susana Vives, MD, Marisa Calabuig, MD, David Gallardo, MD, PhD, Salut Brunet, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2107.
https://doi.org/10.1182/blood.V122.21.2107.2107
Published: 2013
Journal Articles

Prognostic Impact of the Levels of Expression of Cell Surface Proteins Commonly Expressed by Blasts and Hematopoietic Precursor Cells in De Novo AML Patients: A Report From the Spanish Cetlam Study Group

Maria Concepcion Garcia-Dabrio, Montserrat Hoyos, Ana Garrido, Salut Brunet, Rafael F Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Jordi Esteve, MD, PhD, Andreu Llorente, Mar Tormo, Ramon Guardia, Natalia Lloveras, Antoni Garcia, Inmaculada Heras, Juan Besalduch, M. Paz Queipo De Llano, MD, Javier Bueno, Joan Bargay, Pio Torres, Josep M. Marti-Tutusaus, Llorenç Font, Anna Aventin, MD, Quentin Lecrevisse, Alberto Orfao, Jorge Sierra, MD, PhD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2012) 120 (21): 1452.
https://doi.org/10.1182/blood.V120.21.1452.1452
Published: 2012
Journal Articles

WT1 Levels At Diagnosis and POST-Induction Provide Prognostic Information in Adult De Novo AML. Results From the Spanish Cetlam Group.

Josep F Nomdedeu, MD, Montserrat Hoyos, Maite Carricondo, Elena Bussaglia, PhD, Camino Estivill, Jordi Esteve, MD, PhD, Mar Tormo, Rafael F Duarte, MD, PhD, Olga Salamero, MD, PAZ Queipo De Llano, MD, Joan Bargay, Inmaculada Heras, Josep M Marti-Tutusaus, Andreu Llorente, Josep-Maria Ribera, MD, PhD, David Gallardo, MD, PhD, Anna Aventin, MD, Salut Brunet, Jorge Sierra, MD
Journal: Blood
Blood (2012) 120 (21): 2524.
https://doi.org/10.1182/blood.V120.21.2524.2524
Published: 2012
Journal Articles

Comparison of Short-Term Outcomes Between CSTIBES02 and ALL Ph08 Trials for Young Patients with Philadephia Chromosome-Positive ALL (Ph+ALL) Differing In Imatinib Dose and Amount of Chemotherapy Before Stem Cell Transplantation

Josep-Maria Ribera, MD, PhD, Olga Garcia, PhD, Pau Montesinos, MD, Manuel Barrios, Albert Oriol, Salut Brunet, Jose Gonzalez, MD, Jordi Esteve, MD, Mar Tormo, Eloy Del Potro, MD, Maria-José Moreno, Pascual Fernández-Abellán, Jesú S. M.a Hernández-Rivas, MD, PhD, Pere Barba, MD, Josep Sarrá, Eugènia Abella, Maria-Teresa Bernal, Andreu Llorente, Maria-Luz Amigo, Esperanza Lavilla, Pilar Bravo, Miguel-Angel Sanz, MD, Evarist Feliu, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2582.
https://doi.org/10.1182/blood.V118.21.2582.2582
Published: 2011
Journal Articles

Profile of Chronic Transfusion-Dependent Patients In Spain (20CH Study)

Raquel de Paz, Ma Carmen Losada Castillo, Matías Díaz Sánchez, Juan García-Talavera, Teresa Pascual García, Teresa Bernal Del Castillo, Rafael Franco Osorio, Pilar Giraldo, Carmen Pedro, Antoni Julià, Andreu Llorente, Ma Luz Martino Galiana, Marta Dueñas Usategui, Manuel Jurado Chacón, Iñigo Romón, Dolores Morales, Concha Zamora De Pedro, Jose Luis Díez, Isabel Sanjuán, Jordi Sierra Gil, Luis Palomera
Journal: Blood
Blood (2010) 116 (21): 4408.
https://doi.org/10.1182/blood.V116.21.4408.4408
Published: 2010
Journal Articles

Validation of the European Leukemia Net (ELN) Genetic Classification of Acute Myeloid Leukemia: Inclusion of Monosomal Karyotype Improves Prognostic Discrimination

Montserrat Hoyos, Salut Brunet, Josep F. Nomdedeu, MD, Jordi Esteve, MD, PhD, Rafael F. Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, PhD, Andreu Llorente, Ramon Guardia, M. Paz Queipo, Javier Bueno, Juan Besalduch, Pio Torres, Inmaculada Heras, Carmen Pedro, Josep M. Martí-Tutusaus, Antoni Garcia, Joan Bargay, Llorenç Font, Antonia Sampol, MD, PhD, Olga Salamero, MD, David Gallardo, MD, PhD, Lourdes Escoda, Marisa Calabuig, Montserrat Arnan, Marta Pratcorona, Jorge Sierra, MD
Journal: Blood
Blood (2010) 116 (21): 1712.
https://doi.org/10.1182/blood.V116.21.1712.1712
Published: 2010
Journal Articles

Treatment for Primary Acute Myeloid Leukemia: Results of Two Consecutive Trials From the Spanish CETLAM Group Showing Improvement with the Use of G-CSF Priming and Precise Risk-Adapted Therapy.

Jorge Sierra, MD, Montserrat Hoyos, Josep F. Nomdedeu, MD, Jordi Esteve, MD, PhD, Rafael F. Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, PhD, Ramon Guardia, Andreu Llorente, Javier Bueno, Juan Besalduch, M. Paz Queipo, Josep M. Marti-Tutusaus, Carmen Pedro, Pio Torres, Antoni Garcia, Inmaculada Heras, Joan Bargay, Llorenç Font, Jose Gonzalez, Antonia Sampol, MD, PhD, Olga Salamero, MD, Lourdes Escoda, David Gallardo, MD, PhD, Marisa Calabuig, Albert Oriol, Montserrat Arnan, Marta Pratcorona, Salut Brunet
Journal: Blood
Blood (2010) 116 (21): 1066.
https://doi.org/10.1182/blood.V116.21.1066.1066
Published: 2010
Journal Articles

Impact of Cytogenetics and New Molecular Markers On the Achievement of Complete Remission in Patients with Primary Acute Myeloid Leukemia. On Behalf of CETLAM Cooperative Group. Spain.

Salut Brunet, Mar Tormo, Jordi Esteve, Josep M. Ribera, Montserrat Hoyos, Josep F. Nomdedeu, Rafael Duarte, Andreu Llorente, Ramon Guardia, M. Paz Queipo de Llano, Joan Besalduch, Inmaculada Heras, Joan Bargay, Carmen Pedro, Josep M. Marti, Javier Bueno, Pio Torres, Dolores Hernandez, Jose Gonzalez, Antoni Garcia, Llorenç Font, Montserrat Arnan, Albert Oriol, David Gallardo, Rosa Goterris, Emili Montserrat, Jorge Sierra
Journal: Blood
Blood (2009) 114 (22): 4711.
https://doi.org/10.1182/blood.V114.22.4711.4711
Published: 2009
Journal Articles

Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.

Isabel Granada, Salut Brunet, Montserrat Hoyos, Dolors Costa, Anna Aventín, Isabel Marugán, Teresa Vallespí, Marta Barnues, JJ Duarte, Francesc Solé, Montserrat Teixidó, M. Mascaró, Andreu Llorente, Ramon Guardia, Mar Tormo, Rafael F. Duarte, Fuensanta Millá, Jordi Esteve, Josep-Maria Ribera, MD, PhD, Jordi Sierra
Journal: Blood
Blood (2009) 114 (22): 1003.
https://doi.org/10.1182/blood.V114.22.1003.1003
Published: 2009
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial Including the Use of Propensity Score (PS) Method to Reduce Assignment Bias.

Josep-Maria Ribera, Albert Oriol, Mireia Morgades, Miguel-Angel Sanz, Pau Montesinos, Josep Sarra, Salut Brunet, Pascual Fernández-Abellan, Ramon Guardia, Jordi Esteve, Jose Gonzalez-Campos, Arancha Bermudez, Maria-Jose Moreno, Maria-Teresa Bernal, Mar Tormo, Eloy Del Potro, Antonia Cladera, Andreu Llorente, Raimundo Garcia-Boyero, Maria-Jose Rabuñal, Juan Bergua, Carlos Grande, Maria-Luz Amigo, Javier Bueno, Concepcion Bethencourt, Jesus-Maria Hernandez-Rivas, Evarist Feliu
Journal: Blood
Blood (2009) 114 (22): 322.
https://doi.org/10.1182/blood.V114.22.322.322
Published: 2009
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial.

Josep-Maria Ribera, Albert Oriol, Mireia Morgades, Josep Sarra, Pau Montesinos, Salut Brunet, Ramon Guardia, Pascual Fernández-Abellan, Teresa Bernal, MD, Arancha Bermudez, Maria-Jose Moreno, Ricardo Parody, Mar Tormo, Eloy Del Potro, Andreu Llorente, Raimundo Garcia-Boyero, Jordi Esteve, Maria-Jose Rabuñal, Emilia Pardal, Carlos Grande, Javier Bueno, Antonia Cladera, Concepcion Bethencourt, Victoria Martin-Reina, Maria-Luz Amigo, Jesus-Maria Hernandez-Rivas, Miguel-Angel Sanz, Evarist Feliu
Journal: Blood
Blood (2008) 112 (11): 3291.
https://doi.org/10.1182/blood.V112.11.3291.3291
Published: 2008
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Classical Risk Factors and Minimal Residual Disease (MRD). Interim Results of the PETHEMA ALL-AR-03 Trial.

Josep Ribera, MD, Albert Oriol, MD, Mireia Morgades, MD, Josep Sarrá, MD, Salut Brunet, MD, Andreu Llorente, MD, Ramon Guardia, MD, Ricardo Parody, MD, Teresa Bernal, MD, Jordi Esteve, MD, Miguel Sanz, MD, Eloy Del Potro, MD, Juan Bergua, MD, Maria-Jose Moreno, MD, Carlos Grande, MD, Javier Bueno, MD, Antonia Cladera, MD, María-Carmen Fernández, MD, Raimundo García-Boyero, MD, Arancha Bermúdez, MD, Evarist Feliu, MD
Journal: Blood
Blood (2006) 108 (11): 1872.
https://doi.org/10.1182/blood.V108.11.1872.1872
Published: 2006
Journal Articles

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia

Clinical Trials & Observations
Mariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, Alfons Navarro, Granada Perea, Jordi Esteve, Rosa Artells, Miquel Granell, Juan Berlanga, Josep M. Ribera, Javier Bueno, Andreu Llorente, Ramon Guardia, Mar Tormo, Pio Torres, Josep F. Nomdedéu, Emili Montserrat, Jordi Sierra, for CETLAM
Journal: Blood
Blood (2006) 107 (12): 4871–4879.
https://doi.org/10.1182/blood-2005-08-3272
Published: 2006
Journal Articles

Use of Granulocyte Colony-Stimulating Factor (G-CSF) Together with Induction and Intensification Chemotherapy (CT) in Adults with Primary Acute Myeloid Leukemia (AML).

Salut Brunet, Granada Perea, Josep M. Ribera, Jordi Esteve, Mar Tormo, Juan Berlanga, Javier Bueno, Andreu Llorente, Jose M. Moraleda, Ramon Guardia, Joan Besalduch, Pio Torres, Maria Paz Queipo de Llano, Josep M. Marti, Carmen Pedro, Joan Bargay, Josep M. Sanchez, Pilar Vivancos, Evaristo Feliu, Emili Montserrat, Jorge Sierra
Journal: Blood
Blood (2005) 106 (11): 1855.
https://doi.org/10.1182/blood.V106.11.1855.1855
Published: 2005
Journal Articles

Germline Polymorphisms Provide Strong Prognostic Information in Intermediate Risk Acute Myeloblastic Leukemia (AML).

Alvaro Urbano-Ispizua, MD, Salut Brunet, MD, Mariano Monzo, MD, PhD, Granada Perea, MD, Alfons Navarro, PhD, Jordi Esteve, MD, Juan Berlanga, MD, Josep-Maria Ribera, MD, Javier Bueno, MD, Andreu Llorente, MD, Juan Besalduch, MD, Ramon Guardia, MD, Mar Tormo, MD, Carmen Pedro, MD, Juan-Maria Sanchez, MD, Pio Torres, MD, Maria-Paz Queipo de Llano, MD, Llorens Font, MD, Jose-Maria Moraleda, MD, Josep-Maria Marti, MD, Pilar Vivancos, MD, Maria-Jesus Peñarubia, MD, Josep Nomdedeu, MD, Emili Montserrat, MD, Jorge Sierra, MD
Journal: Blood
Blood (2004) 104 (11): 398.
https://doi.org/10.1182/blood.V104.11.398.398
Published: 2004
Journal Articles

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC).

Granada Perea, MD, Adriana Lasa, PhD, Anna Aventin, MD, Alicia Domingo, MD, Neus Villamor, MD, Maria Paz Queipo de LLano, MD, Andreu Llorente, MD, Jordi Junca, MD, Carlos Palacios, MD, Cristalina Fernandez, MD, Miquel Guallart, MD, Llorens Font, MD, Mar Tormo, MD, Lourdes Florensa, MD, Joan Bargay, MD, Josep M. Marti, MD, Pilar Vivancos, MD, Pio Torres, MD, Juan Berlanga, MD, Salut Brunet, MD, Jorge Sierra, MD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2004) 104 (11): 2989.
https://doi.org/10.1182/blood.V104.11.2989.2989
Published: 2004
Journal Articles

ETO sequence may be dispensable in some AML1-ETO leukemias

Adriana Lasa, Josep F. Nomdedéu, Maria J. Carnicer, Andreu Llorente, Jorge Sierra
Journal: Blood
Blood (2002) 100 (12): 4243–4244.
https://doi.org/10.1182/blood-2002-07-2222
Published: 2002